Distinct gene expression signature in Btk-defective T1 B-cells

Biochemical and Biophysical Research Communications

Volumn 346, Issue 2, 2006, Pages 461-469

  Lindvall, Jessica M ^a   Blomberg, K Emelie M ^a   Berglöf, Anna ^a   Smith, C I Edvard ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

B Cells; Gene regulation; Immunodeficiency; Knockout mice; Signal transduction

Indexed keywords

BRUTON TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; MOLECULAR PROBE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; X LINKED AGAMMAGLOBULINEMIA;

ANIMALS; B-LYMPHOCYTE SUBSETS; GENE EXPRESSION PROFILING; MICE; MICE, KNOCKOUT; PROTEIN-TYROSINE KINASES; SPLEEN;

EID: 33745170001     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.146     Document Type: Article

References (57)

1. Vetrie D., Vorechovsky I., Sideras P., Holland J., Davies A., Flinter F., Hammarstrom L., Kinnon C., Levinsky R., Bobrow M., et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361 (1993) 226-233
2. Tsukada S., Saffran D.C., Rawlings D.J., Parolini O., Allen R.C., Klisak I., Sparkes R.S., Kubagawa H., Mohandas T., Quan S., et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72 (1993) 279-290
3. Rawlings D.J., Saffran D.C., Tsukada S., Largaespada D.A., Grimaldi J.C., Cohen L., Mohr R.N., Bazan J.F., Howard M., Copeland N.G., et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261 (1993) 358-361
4. Thomas J.D., Sideras P., Smith C.I.E., Vorechovsky I., Chapman V., and Paul W.E. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261 (1993) 355-358
5. Khan W.N., Alt F.W., Gerstein R.M., Malynn B.A., Larsson I., Rathbun G., Davidson L., Muller S., Kantor A.B., Herzenberg L.A., et al. Defective B cell development and function in Btk-deficient mice. Immunity 3 (1995) 283-299
6. Hendriks R.W., de Bruijn M.F., Maas A., Dingjan G.M., Karis A., and Grosveld F. Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage. EMBO J. 15 (1996) 4862-4872
7. Kerner J.D., Appleby M.W., Mohr R.N., Chien S., Rawlings D.J., Maliszewski C.R., Witte O.N., and Perlmutter R.M. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 3 (1995) 301-312
8. Lindvall J.M., Blomberg K.E.M., Väliaho J., Vargas L., Heinonen J.E., Berglöf A., Mohamed A.J., Vihinen M., and Smith C.I.E. Bruton tyrosine kinase-cell biology, sequence conservation, mutation spectrum, siRNA modifications and expression profiling. Immunol. Rev. 203 (2005) 200-215
9. Smith C.I.E., Islam T.C., Mattsson P.T., Mohamed A.J., Nore B.F., and Vihinen M. The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species. Bioessays 23 (2001) 436-446
10. Miller A.T., and Berg L.J. New insights into the regulation and functions of Tec family tyrosine kinases in the immune system. Curr. Opin. Immunol. 14 (2002) 331-340
11. Takesono A., Finkelstein L.D., and Schwartzberg P.L. Beyond calcium: new signaling pathways for Tec family kinases. J. Cell. Sci. 115 (2002) 3039-3048
12. Salim K., Bottomley M.J., Querfurth E., Zvelebil M.J., Gout I., Scaife R., Margolis R.L., Gigg R., Smith C.I.E., Driscoll P.C., Waterfield M.D., and Panayotou G. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J. 15 (1996) 6241-6250
13. Scharenberg A.M., El-Hillal O., Fruman D.A., Beitz L.O., Li Z., Lin S., Gout I., Cantley L.C., Rawlings D.J., and Kinet J.P. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 17 (1998) 1961-1972
14. Nore B.F., Vargas L., Mohamed A.J., Branden L.J., Backesjo C.M., Islam T.C., Mattsson P.T., Hultenby K., Christensson B., and Smith C.I.E. Redistribution of Bruton's tyrosine kinase by activation of phosphatidylinositol 3-kinase and Rho-family GTPases. Eur. J. Immunol. 30 (2000) 145-154
15. Guo B., Kato R.M., Garcia-Lloret M., Wahl M.I., and Rawlings D.J. Engagement of the human pre-B cell receptor generates a lipid raft-dependent calcium signaling complex. Immunity 13 (2000) 243-253
16. Vargas L., Nore B.F., Berglof A., Heinonen J.E., Mattsson P.T., Smith C.I.E., and Mohamed A.J. Functional interaction of caveolin-1 with Bruton's tyrosine kinase and Bmx. J. Biol. Chem. 277 (2002) 9351-9357
17. Mohamed A.J., Vargas L., Nore B.F., Backesjo C.M., Christensson B., and Smith C.I.E. Nucleocytoplasmic shuttling of Bruton's tyrosine kinase. J. Biol. Chem. 275 (2000) 40614-40619
18. Webb C.F., Yamashita Y., Ayers N., Evetts S., Paulin Y., Conley M.E., and Smith E.A. The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease. J. Immunol. 165 (2000) 6956-6965
19. Rajaiya J., Hatfield M., Nixon J.C., Rawlings D.J., and Webb C.F. Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright. Mol. Cell. Biol. 25 (2005) 2073-2084
20. Islam T.C., and Smith C.I.E. The cellular phenotype conditions Btk for cell survival or apoptosis signaling. Immunol. Rev. 178 (2000) 49-63
21. Uckun F.M., Waddick K.G., Mahajan S., Jun X., Takata M., Bolen J., and Kurosaki T. BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells. Science 273 (1996) 1096-1100
22. Lindvall J., and Islam T.C. Interaction of Btk and Akt in B cell signaling. Biochem. Biophys. Res. Commun. 293 (2002) 1319-1326
23. Liu W., Quinto I., Chen X., Palmieri C., Rabin R.L., Schwartz O.M., Nelson D.L., and Scala G. Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein. Nat. Immunol. 2 (2001) 939-946
24. Campana D., Farrant J., Inamdar N., Webster A.D., and Janossy G. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J. Immunol. 145 (1990) 1675-1680
25. Noordzij J.G., de Bruin-Versteeg S., Comans-Bitter W.M., Hartwig N.G., Hendriks R.W., de Groot R., and van Dongen J.J. Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children. Pediatr. Res. 51 (2002) 159-168
26. Loder F., Mutschler B., Ray R.J., Paige C.J., Sideras P., Torres R., Lamers M.C., and Carsetti R. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190 (1999) 75-89
27. Petro J.B., Gerstein R.M., Lowe J., Carter R.S., Shinners N., and Khan W.N. Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J. Biol. Chem. 277 (2002) 48009-48019
28. Su T.T., and Rawlings D.J. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J. Immunol. 168 (2002) 2101-2110
29. Chung J.B., Sater R.A., Fields M.L., Erikson J., and Monroe J.G. CD23 defines two distinct subsets of immature B cells which differ in their responses to T cell help signals. Int. Immunol. 14 (2002) 157-166
30. Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., Browning J.L., and Mackay F. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192 (2000) 1453-1466
31. Lindvall J.M., Blomberg K.E., Berglof A., Yang Q., Smith C.I.E., and Islam T.C. Gene expression profile of B cells from Xid mice and Btk knockout mice. Eur. J. Immunol. 34 (2004) 1981-1991
32. Tamayo P., Slonim D., Mesirov J., Zhu Q., Kitareewan S., Dmitrovsky E., Lander E.S., and Golub T.R. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc. Natl. Acad. Sci. USA 96 (1999) 2907-2912
33. Li C., and Wong W.H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA 98 (2001) 31-36
34. Zhang B., Kirov S., and Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 33 (2005) W741-W748
35. de Weers M., Verschuren M.C., Kraakman M.E., Mensink R.G., Schuurman R.K., van Dongen J.J., and Hendriks R.W. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. Eur. J. Immunol. 23 (1993) 3109-3114
36. Peng S.L., Gerth A.J., Ranger A.M., and Glimcher L.H. NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity 14 (2001) 13-20
37. Lindvall J.M., Blomberg K.E., Wennborg A., and Smith C.I.E. Differential expression and molecular characterisation of Lmo7, Myo1e, Sash1, and Mcoln2 genes in Btk-defective B-cells. Cell. Immunol. 235 (2005) 46-55
38. Islam T.C., Lindvall J., Wennborg A., Branden L.J., Rabbani H., and Smith C.I.E. Expression profiling in transformed human B cells: influence of Btk mutations and comparison to B cell lymphomas using filter and oligonucleotide arrays. Eur. J. Immunol. 32 (2002) 982-993
39. Ehrlich M., Buchanan K.L., Tsien F., Jiang G., Sun B., Uicker W., Weemaes C.M., Smeets D., Sperling K., Belohradsky B.H., Tommerup N., Misek D.E., Rouillard J.M., Kuick R., and Hanash S.M. DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes. Hum. Mol. Genet. 10 (2001) 2917-2931
40. Feske S., Giltnane J., Dolmetsch R., Staudt L.M., and Rao A. Gene regulation mediated by calcium signals in T lymphocytes. Nat. Immunol. 2 (2001) 316-324
41. Dadi H.K., Simon A.J., and Roifman C.M. Effect of CD3delta deficiency on maturation of alpha/beta and gamma/delta T-cell lineages in severe combined immunodeficiency. N. Engl. J. Med. 349 (2003) 1821-1828
42. Qin H., Yamada M., Tian L., Stewart D.M., Gulino A.V., and Nelson D.L. Tracking gene expression in primary immunodeficiencies. Curr. Opin. Allergy Clin. Immunol. 3 (2003) 437-442
43. Fruman D.A., Ferl G.Z., An S.S., Donahue A.C., Satterthwaite A.B., and Witte O.N. Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes. Proc. Natl. Acad. Sci. USA 99 (2002) 359-364
44. Hogan P.G., Chen L., Nardone J., and Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17 (2003) 2205-2232
45. Berland R., and Wortis H.H. Normal B-1a cell development requires B cell-intrinsic NFATc1 activity. Proc. Natl. Acad. Sci. USA 100 (2003) 13459-13464
46. Antony P., Petro J.B., Carlesso G., Shinners N.P., Lowe J., and Khan W.N. B cell receptor directs the activation of NFAT and NF-kappaB via distinct molecular mechanisms. Exp. Cell Res. 291 (2003) 11-24
47. Iwaki S., Tkaczyk C., Satterthwaite A.B., Halcomb K., Beaven M.A., Metcalfe D.D., and Gilfillan A.M. Btk Plays a Crucial Role in the Amplification of Fc{epsilon}RI-mediated Mast Cell Activation by Kit. J. Biol. Chem. 280 (2005) 40261-40270
48. Hao S., Kurosaki T., and August A. Differential regulation of NFAT and SRF by the B cell receptor via a PLCgamma-Ca(2+)-dependent pathway. EMBO J. 22 (2003) 4166-4177
49. Schneider H., Guerette B., Guntermann C., and Rudd C.E. Resting lymphocyte kinase (Rlk/Txk) targets lymphoid adaptor SLP-76 in the cooperative activation of interleukin-2 transcription in T-cells. J. Biol. Chem. 275 (2000) 3835-3840
50. Tomlinson M.G., Kane L.P., Su J., Kadlecek T.A., Mollenauer M.N., and Weiss A. Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec. Mol. Cell. Biol. 24 (2004) 2455-2466
51. Tsapogas P., Breslin T., Bilke S., Lagergren A., Mansson R., Liberg D., Peterson C., and Sigvardsson M. RNA analysis of B cell lines arrested at defined stages of differentiation allows for an approximation of gene expression patterns during B cell development. J. Leukoc. Biol. 74 (2003) 102-110
52. Hoffmann R., Seidl T., Neeb M., Rolink A., and Melchers F. Changes in gene expression profiles in developing B cells of murine bone marrow. Genome Res. 12 (2002) 98-111
53. Hoffmann R. Gene expression patterns in human and mouse B cell development. Curr. Top. Microbiol. Immunol. 294 (2005) 19-29
54. Genevier H.C., Hinshelwood S., Gaspar H.B., Rigley K.P., Brown D., Saeland S., Rousset F., Levinsky R.J., Callard R.E., Kinnon C., et al. Expression of Bruton's tyrosine kinase protein within the B cell lineage. Eur. J. Immunol. 24 (1994) 3100-3105
55. Smith C.I.E., Baskin B., Humire-Greiff P., Zhou J.N., Olsson P.G., Maniar H.S., Kjellen P., Lambris J.D., Christensson B., Hammarstrom L., et al. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J. Immunol. 152 (1994) 557-565
56. Smith C.I.E., Islam K.B., Vorechovsky I., Olerup O., Wallin E., Rabbani H., Baskin B., and Hammarstrom L. X-linked agammaglobulinemia and other immunoglobulin deficiencies. Immunol. Rev. 138 (1994) 159-183
57. Muller S., Maas A., Islam T.C., Sideras P., Suske G., Philipsen S., Xanthopoulos K.G., Hendriks R.W., and Smith C.I.E. Synergistic activation of the human Btk promoter by transcription factors Sp1/3 and PU.1. Biochem. Biophys. Res. Commun. 259 (1999) 364-369